Evidence map›Paper›PMID 40525140›Full record

ArticleToxicon: X2025

Pathophysiological role of endothelial biomarkers in

Nicole Coelho Lopes, Gdayllon Cavalcante Meneses, Ranieri Sales de Souza Santos, Leticia Machado de Araújo, Bruna Viana Barroso Martins, Katarina Maria Dos Reis Araújo, Valéria Holanda Nogueira de Aquino, Igor Moreira de Almeida, Sandra Mara Brasileiro Mota, Geraldo Bezerra da Silva Junior and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Toxicon: X, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Nicole Coelho LopesPharmacology Post-Graduate Program, Federal University of Ceará, Fortaleza, Ceará, Brazil.
Gdayllon Cavalcante MenesesDepartment of Clinical and Toxicological Analysis Federal University of Fortaleza, Fortaleza, Ceará, Brazil.
Ranieri Sales de Souza SantosPharmacology Post-Graduate Program, Federal University of Ceará, Fortaleza, Ceará, Brazil.
Leticia Machado de AraújoDepartment of Clinical and Toxicological Analysis Federal University of Fortaleza, Fortaleza, Ceará, Brazil.
Bruna Viana Barroso MartinsDepartment of Clinical and Toxicological Analysis Federal University of Fortaleza, Fortaleza, Ceará, Brazil.
Katarina Maria Dos Reis AraújoDepartment of Clinical and Toxicological Analysis Federal University of Fortaleza, Fortaleza, Ceará, Brazil.
Valéria Holanda Nogueira de AquinoDepartment of Clinical and Toxicological Analysis Federal University of Fortaleza, Fortaleza, Ceará, Brazil.
Igor Moreira de AlmeidaPharmacology Post-Graduate Program, Federal University of Ceará, Fortaleza, Ceará, Brazil.
Sandra Mara Brasileiro MotaToxicological Information and Assistance Center, Instituto Doutor Jose Frota Hospital, Fortaleza, Ceará, Brazil.
Geraldo Bezerra da Silva JuniorUniversity of Fortaleza, School of Medicine, Fortaleza, Ceará, Brazil.
Camila Eleuterio RodriguesHospital das Clínicas, University of São Paulo School of Medicine, São Paulo, Brazil.
Elizabeth De Francesco DaherMedical Sciences Post-Graduate Program, Federal University of Ceará, Ceará, Brazil.
Polianna Lemos Moura Moreira AlbuquerqueCharles Darwin University, Darwin, Australia.
Alice Maria Costa MartinsPharmacology Post-Graduate Program, Federal University of Ceará, Fortaleza, Ceará, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Snakebite antivenom (SAV) is the standard treatment option to neutralize the toxic effects of snake venom, but their consequences on kidney function need to be better understood. This study aims to evaluate the effects of antivenom on kidney and endothelial biomarkers due to

Indexed as

AngiopoietinsAntivenomKidney injuryKIM-1SnakebiteVascular cell adhesion molecule-1

Identifiers

PMID40525140
PMCPMC12167772

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.